Pharmacokinetic Analysis of Weekly Versus Biweekly IgPro20 Dosing in Patients With Primary Immunodeficiency

Flexible dosing of IgPro20 (Hizentra®, CSL Behring, King of Prussia, Pennsylvania) maintains normal serum immunoglobulin G (IgG) levels in patients with primary immunodeficiencies (PID). Until now, clinical trials testing the pharmacokinetic (PK) characteristics of serum IgG of weekly and biweekly s...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Pharmacol Drug Dev
Auteurs principaux: Rojavin, Mikhail A., Chapdelaine, Hugo, Tortorici, Michael A., Praus, Michaela, Baheti, Gautam, Zhang, Ying, Hofmann, Jutta, Labrosse, Roxane, Dicaire, Renée, Haddad, Elie
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2019
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7586812/
https://ncbi.nlm.nih.gov/pubmed/31814328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpdd.753
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires